In the context of autoimmune diseases, we demonstrated that blocking TNFα signaling using anti-TNFα antibodies leads to upregulated IFN-I signaling dynamics, while blocking IFN-I-mediated paracrine signaling using JAKi inhibits TNFα production. The gene discussed is TNF; the disease is autoimmune disease.